STOCKHOLM, Sweden, May 6, 2021 (LifeSiteNews) — Sweden’s Karolinska University Hospital will no longer prescribe puberty blockers and cross-sex hormones to children under 16. In a recent statement, the hospital explained why children being treated for gender dysphoria in its affiliated Tema Barn – Astrid Lindgren Children’s Hospital will no longer be given these drugs.
“In December 2019, the SBU (Swedish Agency for Health Technology Assessment and Assessment of Social Services) published an overview of the knowledge base which showed a lack of evidence for both the long-term consequences of the treatments, and the reasons for the large influx of patients in recent years,” the new Karolinska University Hospital policy reads.
“These treatments are potentially fraught with extensive and irreversible adverse consequences such as cardiovascular disease, osteoporosis, infertility, increased cancer risk, and thrombosis,” it continues. “This makes it challenging to assess the risk / benefit for the individual patient, and even more challenging for the minors and their guardians to be in a position of an informed stance regarding these treatments.”
The new policy referred to the December 2020 U.K. High Court decision in the Keira Bell case, in which the court ruled that it was “highly unlikely that a
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
